| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | DesRosier Thomas | Chief Legal Officer and EVP | Feb 16, 2024 | Sale | $1.08 | 3,939 | 4,254 | 120,577 | Feb 16, 2024, 09:48 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | CEO and President | Feb 16, 2024 | Sale | $1.08 | 11,549 | 12,473 | 135,321 | Feb 16, 2024, 09:42 PM | |
| MCRB | Seres Therapeutics, Inc. | Henn Matthew R. | See Remarks | Feb 16, 2024 | Sale | $1.08 | 4,170 | 4,504 | 63,436 | Feb 16, 2024, 09:31 PM | |
| MCRB | Seres Therapeutics, Inc. | Young Teresa L. | See Remarks | Feb 16, 2024 | Sale | $1.08 | 3,374 | 3,644 | 15,705 | Feb 16, 2024, 09:29 PM | |
| MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | Feb 16, 2024 | Sale | $1.08 | 4,400 | 4,752 | 16,988 | Feb 16, 2024, 09:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Ege David S. | See Remarks | Feb 16, 2024 | Sale | $1.08 | 5,010 | 5,411 | 73,856 | Feb 16, 2024, 09:15 PM | |
| MCRB | Seres Therapeutics, Inc. | Arkowitz David | Chief Financial Officer | Feb 16, 2024 | Sale | $1.08 | 3,939 | 4,254 | 182,442 | Feb 16, 2024, 09:13 PM | |
| MCRB | Seres Therapeutics, Inc. | Cloghessy Paula | See Remarks | Oct 30, 2023 | Sale | $1.35 | 2,904 | 3,920 | 45,684 | Oct 31, 2023, 09:43 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | CEO and President | Oct 30, 2023 | Sale | $1.35 | 8,552 | 11,545 | 115,620 | Oct 31, 2023, 09:40 PM | |
| MCRB | Seres Therapeutics, Inc. | Young Teresa L. | See Remarks | Oct 30, 2023 | Sale | $1.35 | 2,907 | 3,924 | 8,454 | Oct 31, 2023, 09:40 PM | |
| MCRB | Seres Therapeutics, Inc. | Arkowitz David | Chief Financial Officer | Oct 30, 2023 | Sale | $1.35 | 4,066 | 5,489 | 175,756 | Oct 31, 2023, 09:39 PM | |
| MCRB | Seres Therapeutics, Inc. | DesRosier Thomas | Chief Legal Officer and EVP | Oct 30, 2023 | Sale | $1.35 | 4,156 | 5,611 | 113,891 | Oct 31, 2023, 09:39 PM | |
| MCRB | Seres Therapeutics, Inc. | Ege David S. | See Remarks | Oct 30, 2023 | Sale | $1.35 | 4,066 | 5,489 | 66,991 | Oct 31, 2023, 09:39 PM | |
| MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | Oct 30, 2023 | Sale | $1.35 | 4,232 | 5,713 | 9,513 | Oct 31, 2023, 09:36 PM | |
| MCRB | Seres Therapeutics, Inc. | Henn Matthew R. | See Remarks | Oct 30, 2023 | Sale | $1.35 | 3,886 | 5,246 | 56,356 | Oct 31, 2023, 09:36 PM | |
| MCRB | Seres Therapeutics, Inc. | Ege David S. | See Remarks | Apr 28, 2023 | Sale | $5.19 | 7,038 | 36,527 | 59,696 | May 01, 2023, 04:46 PM | |
| MCRB | Seres Therapeutics, Inc. | Ege David S. | See Remarks | Oct 31, 2022 | Sale | $7.93 | 5,012 | 39,745 | 46,734 | Oct 31, 2022, 07:37 PM | |
| MCRB | Seres Therapeutics, Inc. | Flagship Pioneering Inc. | 10% Owner | Jul 05, 2022 | Buy | $3.15 | 2,912,748 | 9,175,156 | 5,875,711 | Jul 07, 2022, 05:00 PM | |
| MCRB | Seres Therapeutics, Inc. | Nutritional Health LTP Fund General Partner LLC | 10% Owner | Jul 05, 2022 | Buy | $3.15 | 5,825,495 | 18,350,310 | 5,825,495 | Jul 07, 2022, 05:00 PM | |
| MCRB | Seres Therapeutics, Inc. | DesRosier Thomas | Chief Legal Officer and EVP | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 104,546 | Jul 06, 2022, 07:29 PM | |
| MCRB | Seres Therapeutics, Inc. | Henn Matthew R. | See Remarks | Jul 05, 2022 | Option Exercise | $3.15 | 47,619 | 150,000 | 47,619 | Jul 06, 2022, 07:27 PM | |
| MCRB | Seres Therapeutics, Inc. | Cloghessy Paula | See Remarks | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:25 PM | |
| MCRB | Seres Therapeutics, Inc. | Arkowitz David | Chief Financial Officer | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 65,492 | Jul 06, 2022, 07:23 PM | |
| MCRB | Seres Therapeutics, Inc. | Kender Richard N | Director | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 63,492 | Jul 06, 2022, 07:23 PM | |
| MCRB | Seres Therapeutics, Inc. | Ege David S. | See Remarks | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:22 PM | |
| MCRB | Seres Therapeutics, Inc. | Dere Willard H | Director | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:22 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | CEO and President | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 96,334 | Jul 06, 2022, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Zausner Meryl | Director | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:19 PM | |
| MCRB | Seres Therapeutics, Inc. | Biondi Paul | Director | Jul 05, 2022 | Option Exercise | $3.15 | 47,619 | 150,000 | 47,619 | Jul 06, 2022, 07:19 PM | |
| MCRB | Seres Therapeutics, Inc. | Henn Matthew R. | See Remarks | Dec 01, 2020 | Sale | $17.05 | 171,624 | 2,926,029 | 91,812 | Dec 03, 2020, 04:05 PM | |
| MCRB | Seres Therapeutics, Inc. | Chapman Marcus | See Remarks | Nov 22, 2019 | Sale | $3.91 | 3,400 | 13,297 | 8,600 | Nov 25, 2019, 04:32 PM | |
| MCRB | Seres Therapeutics, Inc. | AFEYAN NOUBAR | Director | Jun 18, 2019 | Buy | $2.25 | 8,888,888 | 19,999,998 | 4,444,444 | Jun 20, 2019, 04:17 PM | |
| MCRB | Seres Therapeutics, Inc. | DesRosier Thomas | Chief Legal Officer and EVP | Jan 28, 2019 | Sale | $5.75 | 5,471 | 31,478 | 16,054 | Jan 29, 2019, 06:55 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | See Remarks | Jan 28, 2019 | Sale | $5.75 | 4,378 | 25,188 | 12,842 | Jan 29, 2019, 06:52 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Dec 17, 2018 | Sale | $6.39 | 14,282 | 91,313 | 75,250 | Dec 19, 2018, 04:11 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | See Remarks | Nov 15, 2018 | Sale | $8.26 | 14,279 | 117,912 | 89,532 | Nov 19, 2018, 04:27 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | See Remarks | Oct 15, 2018 | Sale | $5.94 | 14,279 | 84,800 | 103,811 | Oct 16, 2018, 04:16 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | See Remarks | Aug 15, 2018 | Sale | $7.57 | 14,279 | 108,069 | 132,369 | Sep 19, 2018, 09:22 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | See Remarks | Sep 17, 2018 | Sale | $7.27 | 14,279 | 103,875 | 118,090 | Sep 19, 2018, 09:22 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | See Remarks | May 15, 2018 | Sale | $8.08 | 14,279 | 115,400 | 146,648 | Sep 19, 2018, 09:22 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Sep 05, 2018 | Sale | $9.12 | 9,505 | 86,714 | 218,799 | Sep 06, 2018, 05:08 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Sep 06, 2018 | Sale | $9.04 | 3,013 | 27,235 | 215,786 | Sep 06, 2018, 05:08 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Jul 15, 2018 | Sale | $8.10 | 14,279 | 115,726 | 160,927 | Jul 18, 2018, 04:58 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 11, 2018 | Option Exercise | $4.86 | 2,020 | 9,816 | 229,314 | Jul 12, 2018, 05:15 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 06, 2018 | Option Exercise | $4.93 | 30,732 | 151,417 | 243,670 | Jul 10, 2018, 05:49 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 09, 2018 | Option Exercise | $4.92 | 21,962 | 108,147 | 239,285 | Jul 10, 2018, 05:49 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 10, 2018 | Option Exercise | $4.88 | 11,978 | 58,460 | 234,293 | Jul 10, 2018, 05:49 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 28, 2018 | Option Exercise | $4.93 | 43,120 | 212,683 | 249,864 | Jun 29, 2018, 05:12 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 29, 2018 | Option Exercise | $4.91 | 8,992 | 44,108 | 232,800 | Jun 29, 2018, 05:12 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 27, 2018 | Option Exercise | $4.87 | 33,982 | 165,472 | 245,295 | Jun 27, 2018, 09:06 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 25, 2018 | Option Exercise | $6.00 | 43,040 | 258,068 | 255,056 | Jun 27, 2018, 09:06 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 26, 2018 | Option Exercise | $4.95 | 42,448 | 210,203 | 249,528 | Jun 27, 2018, 09:06 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 20, 2018 | Sale | $9.33 | 26,492 | 247,051 | 297,812 | Jun 22, 2018, 09:11 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 21, 2018 | Sale | $9.06 | 18,987 | 172,094 | 278,825 | Jun 22, 2018, 09:11 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 22, 2018 | Sale | $9.36 | 40,057 | 374,761 | 238,768 | Jun 22, 2018, 09:11 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Jun 15, 2018 | Sale | $8.57 | 14,279 | 122,325 | 170,206 | Jun 18, 2018, 04:43 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 09, 2018 | Sale | $9.00 | 233 | 2,097 | 324,304 | May 10, 2018, 04:44 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Apr 25, 2018 | Sale | $7.58 | 14,279 | 108,266 | 184,485 | Apr 26, 2018, 04:55 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | See Remarks | Jan 26, 2018 | Sale | $11.02 | 1,738 | 19,153 | 198,764 | Jan 30, 2018, 09:01 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | See Remarks | Jan 26, 2018 | Sale | $11.02 | 2,780 | 30,636 | 5,220 | Jan 30, 2018, 09:01 PM | |
| MCRB | Seres Therapeutics, Inc. | DesRosier Thomas | See Remarks | Jan 26, 2018 | Sale | $11.02 | 3,475 | 38,295 | 6,525 | Jan 30, 2018, 08:58 PM | |
| MCRB | Seres Therapeutics, Inc. | Trucksis Michele | See Remarks | Jan 26, 2018 | Sale | $11.02 | 2,607 | 28,729 | 4,893 | Jan 30, 2018, 08:58 PM | |
| MCRB | Seres Therapeutics, Inc. | COOK DAVID N | See Remarks | Jan 26, 2018 | Sale | $11.02 | 1,738 | 19,153 | 139,935 | Jan 30, 2018, 08:58 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | See Remarks | Dec 19, 2017 | Sale | $10.14 | 1,623 | 16,457 | 195,502 | Jan 30, 2018, 08:54 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jan 24, 2018 | Option Exercise | $0.71 | 40,241 | 28,571 | 324,537 | Jan 25, 2018, 04:39 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Dec 19, 2017 | Sale | $10.14 | 1,623 | 16,457 | 59,437 | Dec 20, 2017, 04:56 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 18, 2017 | Option Exercise | $0.71 | 100,604 | 71,429 | 284,296 | Jul 20, 2017, 04:36 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Apr 25, 2016 | Sale | $31.94 | 18,640 | 595,362 | 56,060 | Aug 31, 2016, 08:47 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Aug 29, 2016 | Sale | $10.87 | 9,390 | 102,069 | 192,125 | Aug 30, 2016, 07:23 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Jul 27, 2016 | Sale | $35.00 | 9,250 | 323,750 | 201,515 | Jul 29, 2016, 04:50 PM | |
| MCRB | Seres Therapeutics, Inc. | Trucksis Michele | Chief Medical Officer and EVP | Jul 28, 2016 | Option Exercise | $25.47 | 8,312 | 211,747 | 4,156 | Jul 29, 2016, 04:49 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 27, 2016 | Option Exercise | $17.85 | 40,000 | 714,200 | 203,692 | Jul 28, 2016, 06:01 PM | |
| MCRB | Seres Therapeutics, Inc. | Trucksis Michele | Chief Medical Officer and EVP | Jul 27, 2016 | Option Exercise | $25.45 | 76,128 | 1,937,781 | 38,064 | Jul 28, 2016, 06:00 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Jul 22, 2016 | Option Exercise | $0.48 | 187,500 | 90,000 | 220,155 | Jul 26, 2016, 05:54 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Jul 25, 2016 | Sale | $34.18 | 9,390 | 320,950 | 210,765 | Jul 26, 2016, 05:54 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 06, 2016 | Sale | $15.18 | 70,870 | 1,075,875 | 219,127 | Jul 07, 2016, 05:27 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 05, 2016 | Option Exercise | $15.01 | 105,552 | 1,584,229 | 236,468 | Jul 07, 2016, 05:27 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jul 01, 2016 | Sale | $15.26 | 113,578 | 1,733,025 | 240,481 | Jul 05, 2016, 05:30 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | CFO and EVP | Jun 30, 2016 | Sale | $18.67 | 9,066 | 169,217 | 4,533 | Jun 30, 2016, 05:46 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Jun 27, 2016 | Sale | $27.23 | 9,390 | 255,690 | 32,655 | Jun 29, 2016, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | CFO and EVP | Jun 27, 2016 | Option Exercise | $17.89 | 6,668 | 119,324 | 3,334 | Jun 29, 2016, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | CFO and EVP | Jun 28, 2016 | Option Exercise | $18.32 | 3,334 | 61,079 | 1,667 | Jun 29, 2016, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 02, 2016 | Sale | $16.61 | 148,098 | 2,460,490 | 257,741 | Jun 06, 2016, 04:30 PM | |
| MCRB | Seres Therapeutics, Inc. | COOK DAVID N | Chief Scientific Officer & EVP | Jun 02, 2016 | Sale | $31.00 | 8,000 | 248,000 | 136,673 | Jun 06, 2016, 04:27 PM | |
| MCRB | Seres Therapeutics, Inc. | COOK DAVID N | Chief Scientific Officer & EVP | Jun 01, 2016 | Sale | $29.43 | 16,000 | 470,880 | 144,673 | Jun 02, 2016, 09:38 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Jun 01, 2016 | Option Exercise | $15.61 | 141,902 | 2,215,213 | 254,643 | Jun 02, 2016, 09:37 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | May 31, 2016 | Sale | $30.05 | 14,015 | 421,088 | 42,695 | Jun 02, 2016, 09:34 PM | |
| MCRB | Seres Therapeutics, Inc. | Flagship Ventures Fund 2007, L.P. | 10% Owner | May 25, 2016 | Sale | $27.60 | 1,000,000 | 27,600,000 | 2,734,994 | May 27, 2016, 06:43 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 24, 2016 | Sale | $15.35 | 19,602 | 300,989 | 193,493 | May 25, 2016, 09:11 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 18, 2016 | Option Exercise | $0.71 | 160,965 | 114,285 | 183,692 | May 19, 2016, 04:41 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 06, 2016 | Sale | $12.51 | 17,014 | 212,842 | 31,234 | May 09, 2016, 09:31 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 05, 2016 | Option Exercise | $13.22 | 60,054 | 794,061 | 43,854 | May 06, 2016, 04:28 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 04, 2016 | Option Exercise | $13.62 | 58,596 | 798,338 | 51,325 | May 06, 2016, 04:28 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 02, 2016 | Sale | $14.89 | 87,374 | 1,301,036 | 66,414 | May 04, 2016, 05:06 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | May 03, 2016 | Sale | $14.36 | 47,360 | 679,992 | 46,407 | May 04, 2016, 05:06 PM | |
| MCRB | Seres Therapeutics, Inc. | Aunins John G. | Chief Technology Officer & EVP | Apr 25, 2016 | Sale | $31.94 | 18,640 | 595,362 | 56,060 | Apr 27, 2016, 04:44 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Apr 07, 2016 | Sale | $15.33 | 18,424 | 282,507 | 31,939 | Apr 11, 2016, 05:47 PM | |
| MCRB | Seres Therapeutics, Inc. | COOK DAVID N | Chief Scientific Officer & EVP | Apr 07, 2016 | Sale | $31.00 | 8,000 | 248,000 | 160,673 | Apr 11, 2016, 05:47 PM | |
| MCRB | Seres Therapeutics, Inc. | Shaff Eric D. | CFO and EVP | Apr 04, 2016 | Sale | $18.32 | 13,136 | 240,652 | 6,568 | Apr 06, 2016, 05:44 PM | |
| MCRB | Seres Therapeutics, Inc. | Pomerantz Roger | President and CEO | Apr 01, 2016 | Sale | $13.42 | 181,926 | 2,440,965 | 113,690 | Apr 05, 2016, 08:59 PM |
Menu